Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2022 3
2023 10
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Safety and Effectiveness of Chemotherapy in Elderly Biliary Tract Cancer Patients.
Okamoto T, Takeda T, Sasaki T, Hamada T, Mie T, Ishitsuka T, Yamada M, Nakagawa H, Hirai T, Furukawa T, Kasuga A, Ozaka M, Sasahira N. Okamoto T, et al. Among authors: ishitsuka t. Curr Oncol. 2023 Jul 27;30(8):7229-7240. doi: 10.3390/curroncol30080524. Curr Oncol. 2023. PMID: 37623005 Free PMC article.
Impact of the COVID-19 Pandemic on the Management and End-of-life Care of Unresectable Pancreatic Cancer.
Kasuga A, Nojima M, Okamoto T, Ishitsuka T, Yamada M, Nakagawa H, Udagawa S, Mori C, Mie T, Furukawa T, Yamada Y, Takeda T, Matsuyama M, Sasaki T, Ozaka M, Sasahira N. Kasuga A, et al. Among authors: ishitsuka t. Intern Med. 2022 Dec 15;61(24):3641-3649. doi: 10.2169/internalmedicine.0492-22. Epub 2022 Oct 5. Intern Med. 2022. PMID: 36198597 Free PMC article.
Impact of the Extent of Weight Loss before Administration on the Efficacy of Anamorelin in Advanced Pancreatic Cancer Patients with Cachexia.
Takeda T, Sasaki T, Okamoto T, Ishitsuka T, Yamada M, Nakagawa H, Mie T, Furukawa T, Kasuga A, Matsuyama M, Ozaka M, Sasahira N. Takeda T, et al. Among authors: ishitsuka t. Intern Med. 2023 Jul 1;62(13):1887-1893. doi: 10.2169/internalmedicine.0730-22. Epub 2022 Nov 23. Intern Med. 2023. PMID: 36418096 Free PMC article.
Treatment Outcomes and Prognostic Factors of Gemcitabine Plus Nab-Paclitaxel as Second-Line Chemotherapy after Modified FOLFIRINOX in Unresectable Pancreatic Cancer.
Mie T, Sasaki T, Takeda T, Okamoto T, Hamada T, Ishitsuka T, Yamada M, Nakagawa H, Furukawa T, Kasuga A, Matsuyama M, Ozaka M, Sasahira N. Mie T, et al. Among authors: ishitsuka t. Cancers (Basel). 2023 Jan 5;15(2):358. doi: 10.3390/cancers15020358. Cancers (Basel). 2023. PMID: 36672308 Free PMC article.
13 results